- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.06. | Wellgistics Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.06. | Wellgistics Health, Inc.: Wellgistics Health Provides Mid-Year 2026 Corporate Outlook | 364 | ACCESS Newswire | Focus is on closing DelivMeds AI transaction, driving pharmacy revenue growth and supporting PharmacyChain, Medical Drones and Health Lives Here progressRecent capital raise provides capital into late... ► Artikel lesen | |
| 29.05. | Wellgistics Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 28.05. | Wellgistics: Aktionäre vereinbaren 90-tägige Sperrfrist für Aktien | 2 | Investing.com Deutsch | ||
| 28.05. | Wellgistics shareholders agree to 90-day share lock-up | 5 | Investing.com | ||
| WELLGISTICS HEALTH Aktie jetzt für 0€ handeln | |||||
| 28.05. | Wellgistics Health, Inc.: Wellgistics Health Announces Lock-Up Agreement with Holders of a Majority of its Common Stock | 392 | ACCESS Newswire | Holders of 1,333,930 common shares agree to minimum 90-day lock-up agreement TAMPA, FL / ACCESS Newswire / May 28, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader,... ► Artikel lesen | |
| 28.05. | Wellgistics Health, Inc.: Wellgistics Health Refinances Outstanding Convertible Debt and Raises $6.5M | 700 | ACCESS Newswire | New oversubscribed $21 million convertible debt instrument ("New Debt") refinances all outstanding convertible debt, provides $6.5 million in new capital for working capital and general corporate purposes... ► Artikel lesen | |
| 26.05. | Wellgistics Health, Inc.: Wellgistics Health Completes Reverse Split | 480 | ACCESS Newswire | 1-for-50 reverse split of common shares outstanding now complete2,513,425 common shares now outstandingA new CUSIP was issued in connection with reverse split TAMPA, FL / ACCESS Newswire / May 26, 2026... ► Artikel lesen | |
| 21.05. | Wellgistics Health, Inc.: Wellgistics Health Releases Letter to Our Shareholders | 518 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / May 21, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization... ► Artikel lesen | |
| 21.05. | Why Wellgistics Health (WGRX) Stock Fell Over 24% After Hours? | 3 | Benzinga.com | ||
| 21.05. | Wellgistics Health announces 1-for-50 reverse stock split to regain Nasdaq compliance | 6 | Seeking Alpha | ||
| 21.05. | Wellgistics Health approves 1-for-50 reverse stock split | 2 | Investing.com | ||
| 21.05. | Wellgistics Health, Inc.: Wellgistics Health Announces Reverse Stock Split | 530 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / May 20, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a health information technology leader, integrating proprietary pharmacy dispensing... ► Artikel lesen | |
| 19.05. | Wellgistics Health GAAP EPS of -$0.07 | 1 | Seeking Alpha | ||
| 19.05. | Wellgistics Health, Inc.: Wellgistics Health Reports First Quarter 2026 Financials and Provides Business Update | 579 | ACCESS Newswire | Wellgistics Pharmacy monthly revenue increased from approximately $0.1 million in November 2025 to approximately $0.6 million in April 2026, based on preliminary unaudited resultsQ1-26 focus on optimization... ► Artikel lesen | |
| 19.05. | Wellgistics Health, Inc. - 10-Q, Quarterly Report | 4 | SEC Filings | ||
| 18.05. | Wellgistics Health zieht vorläufige Stimmrechtsunterlagen zurück und prüft strategische Optionen | 3 | Investing.com Deutsch | ||
| 18.05. | Wellgistics Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.05. | Wellgistics Health, Inc.: Wellgistics Health to Announce First Quarter 2026 Financials on Tuesday May 19, 2026 | 410 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / May 15, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a leading healthcare technology and pharmaceutical distribution company, today announced... ► Artikel lesen | |
| 14.05. | Wellgistics Health treibt die digitale Expansion seines kürzlich angekündigten Pilotprojekts für RPM, R und CCM mit der geplanten Übernahme von WellCare Today und dessen firmeneigenem Samsung Galaxy Watch-Programm zur Gesundheitsüberwachung ... | 990 | IR-WORLD | Highlights:
- WellCare Today bringt eine etablierte RPM-, RTM- und CCM-Infrastruktur mit Integrationen in Wearable-Technologien und vernetzten
Überwachungslösungen mit
... ► Artikel lesen |
1 2 3 4 5 Weiter >>
86 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TILRAY BRANDS | 4,070 | +0,37 % | Tilray Brands, Inc.: Hi*Ball Energy erobert Großbritannien und wird zum Vorreiter des neuen "Clean Energy"-Trends | Neue Energie tanken mit Hi*Ball Sparkling Energy Water: Der innovative Energydrink kombiniert natürliches Koffein und funktionelle Inhaltsstoffe mit vollem Geschmack - ohne Zucker, ohne Kalorien und... ► Artikel lesen | |
| VIATRIS | 13,850 | +0,16 % | VTRS vs. DHR: Which Stock Is the Better Value Option? | ||
| SYNBIOTIC | 1,168 | -3,47 % | EQS-Adhoc: SYNBIOTIC SE: Hempro International GmbH beabsichtigt Antrag auf Eröffnung eines vorläufigen Insolvenzverfahrens | EQS-Ad-hoc: SYNBIOTIC SE / Schlagwort(e): Insolvenz/Angespannte wirtschaftliche Situation
Hempro International GmbH beabsichtigt Antrag auf Eröffnung eines vorläufigen Insolvenzverfahrens... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 10,315 | -1,90 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA, Expanding Total Commercial Coverage to ~52 Million U.S. Lives | Agreement with second leading group purchasing organization (GPO), effective June 1, 2026, provides access to approximately 17 million additional U.S. commercial lives (10% of the ~177 million commercial... ► Artikel lesen | |
| ZEALAND PHARMA | 37,720 | -1,10 % | Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons | ||
| SELLAS LIFE SCIENCES | 7,920 | -0,50 % | DesignRush: Brooke Sellas Joins DesignRush Podcast on Social Media's Revenue Risk | Miami, Florida--(Newsfile Corp. - June 23, 2026) - The latest episode of the DesignRush Podcast features Brooke Sellas, founder and CEO of B Squared Media. The episode explores why companies risk... ► Artikel lesen | |
| UNITED THERAPEUTICS | 476,60 | -0,38 % | United Therapeutics Corp Q1 Income Declines | WASHINGTON (dpa-AFX) - United Therapeutics Corp (UTHR) released a profit for first quarter that Dropped, from last yearThe company's bottom line came in at $274.9 million, or $5.82 per share.... ► Artikel lesen | |
| XORTX THERAPEUTICS | 1,755 | -3,26 % | XORTX Therapeutics Inc (4): XORTX $5-million (U.S.) prospectus offering | ||
| TG THERAPEUTICS | 48,200 | +1,69 % | TG Therapeutics, Inc.: TG Therapeutics Announces Positive Topline Phase 1 Data for Subcutaneous BRIUMVI in Patients with Myasthenia Gravis and Initiation of Potential Registration Directed Randomized Phase 2 Trial | 82% of subjects achieved an MCID in their MG-ADL with a mean >4 point improvement in MG-ADL observed in Phase 1 study of Subcutaneous BRIUMVI in patients with MG (n=11) Potential registration-directed... ► Artikel lesen | |
| SOLIGENIX | 0,387 | +1,65 % | SOLIGENIX, INC.: Soligenix Announces Recent Updates and First Quarter 2026 Financial Results | PRINCETON, N.J., May 8, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing... ► Artikel lesen | |
| TALPHERA | 0,905 | 0,00 % | TALPHERA, INC. - 8-K, Current Report | ||
| SAVARA | 5,012 | -1,26 % | Savara Inc.: Savara Announces the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) Has Accepted the MOLBREEVI* Marketing Authorisation Application (MAA) for Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) | -- MHRA's Acceptance Follows Acceptance/Validation of MOLBREEVI Biologics License Application (BLA) and MAA in Autoimmune PAP by the U.S. Food and Drug Administration (FDA) and the European Medicines... ► Artikel lesen | |
| SCYNEXIS | 3,850 | +0,79 % | XFRA 135: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSCYNEXIS INC. DL... ► Artikel lesen | |
| THERIVA BIOLOGICS | 0,248 | 0,00 % | Theriva Biologics, Inc.: Theriva Biologics Announces Results from VCN-01 Phase 1 Clinical Trial in Head and Neck Cancer Published in Clinical Cancer Research | - Prolonged overall survival (OS) was observed in heavily pre-treated refractory Head & Neck Squamous Cell Carcinoma (HNSCC) patients administered IV VCN-01 prior to the immune checkpoint inhibitor... ► Artikel lesen | |
| WAVE LIFE SCIENCES | 5,300 | 0,00 % | Wave Life Sciences Ltd.: Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing | Data reinforce WVE-006's potential to address both lung and liver manifestations of AATD with a durable, convenient, and safe therapy capable of recapitulating the protective MZ-like phenotype with... ► Artikel lesen |
Das Unternehmen WELLGISTICS HEALTH INC kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell +0,64 % bei einem Aktienkurs von 3,140 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu WELLGISTICS HEALTH INC finden Sie auf Wallstreet Online.